17-octadecynoic acid has been researched along with Glioblastoma in 1 studies
octadec-17-ynoic acid : An acetylenic fatty acid that is octadecanoi acid (stearic acid) which has been doubly dehydrogenated at positions 17 and 18 to give the corresponding alkynoic acid.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zagorac, D | 1 |
| Jakovcevic, D | 1 |
| Gebremedhin, D | 1 |
| Harder, DR | 1 |
1 other study available for 17-octadecynoic acid and Glioblastoma
| Article | Year |
|---|---|
Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Antifungal Agents; Antineoplastic Agents; Arachidonic Acid; Ar | 2008 |